In this single-center retrospective study from a cohort of 3,046 patients confirmed with COVID-19 at Wuhan Huoshenshan Hospital in China, the effectiveness of using cardiac markers including BNP, hs-TNI, α-HBDH, CK-MB, and LDH to predict mortality in patients with and without CAD upon admission was investigated. The gene discussed is NPPB; the disease is coronary artery disorder.